Passa al contenuto
Merck
Tutte le immagini(1)

Documenti

EPS002

Sigma-Aldrich

MS-275

A HDAC1 and HDAC3 inhibitor

Sinonimo/i:

MS-275 (Entinostat, SNDX-275), 3-pyridinylmethyl [[4-[[(2-aminophenyl)amino]carbonyl]phenyl]methyl]carbamate, N-(2-Aminophenyl)-4-[N-(pyridine-3ylmethoxycarbonyl)aminomethyl]benzamide

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(1)

About This Item

Formula empirica (notazione di Hill):
C21H20N4O3
Numero CAS:
209783-80-2
Peso molecolare:
376.41
Numero MDL:
MFCD03453552
Codice UNSPSC:
12352200
ID PubChem:
329799578
NACRES:
NA.41

Saggio

≥99%

Solubilità

DMSO: 38 mg/mL

Temperatura di conservazione

−20°C

Stringa SMILE

Nc1ccccc1NC(=O)c2ccc(CNC(=O)OCc3cccnc3)cc2

InChI

1S/C21H20N4O3/c22-18-5-1-2-6-19(18)25-20(26)17-9-7-15(8-10-17)13-24-21(27)28-14-16-4-3-11-23-12-16/h1-12H,13-14,22H2,(H,24,27)(H,25,26)
INVTYAOGFAGBOE-UHFFFAOYSA-N

Informazioni sul gene

human ... HDAC1(3065) , HDAC10(83933) , HDAC11(79885) , HDAC2(3066) , HDAC3(8841) , HDAC4(9759) , HDAC5(10014) , HDAC6(10013) , HDAC7(51564) , HDAC8(55869) , HDAC9(9734)

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Descrizione generale

Preferentially inhibits HDAC1 (IC50=300 nM) over HDAC3 (IC50=8 μM). Has no inhibitory activity towards HDAC8 (IC50>100 μM).

Applicazioni

MS-275 has been used as a histone deacetylase-1 inhibitor.

Azioni biochim/fisiol

HDAC inhibitor; antiproliferative.

Pittogrammi

Skull and crossbonesHealth hazard
GHS06,GHS08

Avvertenze

Danger

Indicazioni di pericolo

H301,H360

Classi di pericolo

Acute Tox. 3 Oral - Repr. 1A

Codice della classe di stoccaggio

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

Classe di pericolosità dell'acqua (WGK)

WGK 3

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable

Certificati d'analisi (COA)

Cerca il Certificati d'analisi (COA) digitando il numero di lotto/batch corrispondente. I numeri di lotto o di batch sono stampati sull'etichetta dei prodotti dopo la parola ‘Lotto’ o ‘Batch’.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Slide 1 of 9

1 of 9

Scriptaid ≥95%, solid

Sigma-Aldrich

S7817

Scriptaid

LMK235 ≥98% (HPLC)

Sigma-Aldrich

SML1053

LMK235

Tubacin ≥98% (HPLC)

Sigma-Aldrich

SML0065

Tubacin

M344 ≥98% (HPLC), powder

Sigma-Aldrich

M5820

M344

Apicidin ≥98% (HPLC), from microbial

Sigma-Aldrich

A8851

Apicidin

5-azacitidina ≥98% (HPLC)

Sigma-Aldrich

A2385

5-azacitidina

EX-527 ≥98% (HPLC)

Sigma-Aldrich

E7034

EX-527

Trichostatin A, Ready Made Solution 5 mM in DMSO, from Streptomyces sp.

Sigma-Aldrich

T1952

Trichostatin A, Ready Made Solution

UNC0638 hydrate ≥98% (HPLC)

Sigma-Aldrich

U4885

UNC0638 hydrate

Heather MacTavish et al.
PloS one, 5(12), e14462-e14462 (2011-02-02)
Histone deacetylase inhibitors (HDI) dampen cellular innate immune response by decreasing interferon production and have been shown to increase the growth of vesicular stomatitis virus and HSV. As attenuated tumour-selective oncolytic vaccinia viruses (VV) are already undergoing clinical evaluation, the
HoxC5 and miR-615-3p target newly evolved genomic regions to repress hTERT and inhibit tumorigenesis
TingDong Y et al.
Nature Communications, 100 (2018)
Marta Bombardo et al.
Scientific reports, 8(1), 9391-9391 (2018-06-22)
Adult pancreatic acinar cells have the ability to re-enter the cell cycle and proliferate upon injury or tissue loss. Despite this mitotic ability, the extent of acinar proliferation is often limited and unable to completely regenerate the injured tissue or
Guido Dentesano et al.
Journal of neuroinflammation, 9, 165-165 (2012-07-11)
In physiological conditions, it is postulated that neurons control microglial reactivity through a series of inhibitory mechanisms, involving either cell contact-dependent, soluble-factor-dependent or neurotransmitter-associated pathways. In the current study, we focus on CD200R1, a microglial receptor involved in one of
Xuelian Xu et al.
PloS one, 6(2), e17138-e17138 (2011-03-02)
Pediatric acute myeloid leukemia (AML) remains a challenging disease to treat even with intensified cytarabine-based chemotherapy. Histone deacetylases (HDACs) have been reported to be promising therapeutic targets for treating AML. However, HDAC family members that are involved in chemotherapy sensitivities
Visualizza tutti i documenti correlati

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.